OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, biological evaluation and molecular docking studies of new pyrimidine derivatives as potent dual EGFR/HDAC inhibitors
G. Sivaiah, M.S. Raghu, S. Prasad, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138223-138223
Closed Access | Times Cited: 12

Showing 12 citing articles:

Synthesis, anticancer and antioxidant activities of novel heterocyclic phenolic hydrazone based derivatives: Investigation of DFT calculation, molecular docking and drug-likeness studies
Ai‐Ping Xing, Pengbo Zhu, Bin Zhang, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139523-139523
Closed Access | Times Cited: 5

Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access

Design, Synthesis, and Molecular Docking of Novel Benzothiazinone Derivatives as DprE1 Inhibitors with Potential Antitubercular Activities
M.S. Raghu, Amar Yasser Jassim, K. Yogesh Kumar, et al.
Russian Journal of Bioorganic Chemistry (2025) Vol. 51, Iss. 1, pp. 65-78
Closed Access

Structure-Based Design of New LSD1/EGFRL858R/T790M Dual Inhibitors for Treating EGFR Mutant NSCLC Cancers
Jingya Zhang, Pengxing He, Wenwen Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents
Jie Peng, Hongyan Liu, Yujing Liu, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107818-107818
Closed Access | Times Cited: 3

Pyrimidines: A New Versatile Molecule in the Drug Development Field, Scope, and Future Aspects
Katharigatta N. Venugopala, Vinuta Kamat
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1258-1258
Open Access | Times Cited: 3

Synthesis, and molecular docking studies of novel 1,2,3-triazoles-linked pyrazole carboxamides as significant anti-microbial and anti-cancer agents
Leila Kamrani Tamardash, Mohammad Bakherad, Hamid Bakherad, et al.
Results in Chemistry (2024) Vol. 11, pp. 101842-101842
Open Access | Times Cited: 3

Synthesis and histone deacetylases inhibitory activity of pyrimidine‐based 1,3,4‐oxadiazoles
Virginija Jakubkienė, I. Labalaukyte, Markus Schweipert, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 9, pp. 1426-1438
Closed Access

Comparative analysis of RCC and PT Slabs underneath Lateral Loading: A Structural study using ETABS
Koushal Dhamija, Vegiraju Naresh Kumar Varma, Manish Gupta, et al.
E3S Web of Conferences (2024) Vol. 552, pp. 01140-01140
Open Access

Exploring the cytotoxicity and DNA binding studies of green synthesized europium stannate nanoparticle through experimental and computational approach
M.S. Raghu, S Bindu, Amar Yasser Jassim, et al.
Materials Chemistry and Physics (2024), pp. 130327-130327
Closed Access

Page 1

Scroll to top